Delivery Order SPE2DB22D3301-SPE2DB24FZ1CC
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,615.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00, which enables the DLA to efficiently procure a wide...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order (contract #SPE2DB20D1047|SPE2DB24FF60Z) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564232214 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award, with a ceiling value of $5,772.01, has an ultimate completion date of April 11, 2024. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through...
This is a $9,480.42 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a period of performance through March 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a ceiling value of $4,091.91 and a performance period through May 8, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any specific business category....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a prescription medication, with a ceiling value of $1,641.14 and a period of performance through April 30, 2025. The contract is not set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,050.24 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of LIKMEZ 500 MG/5 ML SUSPENSION 200ML, a pharmaceutical product, and has a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $70,093.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, awarded on August 5, 2024, has an ultimate completion date of August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,020.26 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The U.S. government awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,565.76, has an ultimate completion date of August 14, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $13,353.60 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 24, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...